<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Reported-in-House" bill-type="olc" dms-id="H3FF724E4E5814AFB8B373571D058DB68" key="H" public-private="public"> 
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>115 HR 1222 RH: Congenital Heart Futures Reauthorization Act of 2017</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2017-02-27</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">IB</distribution-code> 
<calendar display="yes">Union Calendar No. 239</calendar> 
<congress display="yes">115th CONGRESS</congress><session display="yes">1st Session</session> 
<legis-num display="yes">H. R. 1222</legis-num> 
<associated-doc display="yes" role="report">[Report No. 115–329]</associated-doc> 
<current-chamber display="yes">IN THE HOUSE OF REPRESENTATIVES</current-chamber> 
<action display="yes"> 
<action-date date="20170227">February 27, 2017</action-date> 
<action-desc><sponsor name-id="B001257">Mr. Bilirakis</sponsor> (for himself and <cosponsor name-id="S001150">Mr. Schiff</cosponsor>) introduced the following bill; which was referred to the <committee-name added-display-style="italic" committee-id="HIF00" deleted-display-style="strikethrough">Committee on Energy and Commerce</committee-name></action-desc> 
</action> 
<action>
<action-date>September 25, 2017</action-date>
<action-desc>Additional sponsors: <cosponsor name-id="A000374">Mr. Abraham</cosponsor>, <cosponsor name-id="S001193">Mr. Swalwell of California</cosponsor>, <cosponsor name-id="L000565">Mr. Loebsack</cosponsor>, <cosponsor name-id="B001295">Mr. Bost</cosponsor>, <cosponsor name-id="S001200">Mr. Soto</cosponsor>, <cosponsor name-id="P000607">Mr. Pocan</cosponsor>, <cosponsor name-id="M001159">Mrs. McMorris Rodgers</cosponsor>, <cosponsor name-id="M001202">Mrs. Murphy of Florida</cosponsor>, <cosponsor name-id="W000806">Mr. Webster of Florida</cosponsor>, <cosponsor name-id="M001190">Mr. Mullin</cosponsor>, <cosponsor name-id="E000296">Mr. Evans</cosponsor>, <cosponsor name-id="S001187">Mr. Stivers</cosponsor>, <cosponsor name-id="G000558">Mr. Guthrie</cosponsor>, <cosponsor name-id="C001078">Mr. Connolly</cosponsor>, <cosponsor name-id="N000147">Ms. Norton</cosponsor>, <cosponsor name-id="N000127">Mr. Nolan</cosponsor>, <cosponsor name-id="F000466">Mr. Fitzpatrick</cosponsor>, <cosponsor name-id="C001092">Mr. Collins of New York</cosponsor>, <cosponsor name-id="V000081">Ms. Velázquez</cosponsor>, <cosponsor name-id="R000435">Ms. Ros-Lehtinen</cosponsor>, <cosponsor name-id="S000250">Mr. Sessions</cosponsor>, <cosponsor name-id="G000568">Mr. Griffith</cosponsor>, <cosponsor name-id="E000288">Mr. Ellison</cosponsor>, <cosponsor name-id="M001196">Mr. Moulton</cosponsor>, <cosponsor name-id="C001097">Mr. Cárdenas</cosponsor>, <cosponsor name-id="W000798">Mr. Walberg</cosponsor>, and <cosponsor name-id="M001181">Mr. Meehan</cosponsor></action-desc>
</action>
<action> 
<action-date>September 25, 2017</action-date> 
<action-desc>Reported with an amendment, committed to the Committee of the Whole House on the State of the Union, and ordered to be printed</action-desc> 
<action-instruction>Strike out all after the enacting clause and insert the part printed in italic</action-instruction> 
<action-instruction>For text of introduced bill, see copy of bill as introduced on February 27, 2017</action-instruction> 
</action> 
<action display="yes"> 
<action-desc display="yes"><pagebreak/></action-desc> 
</action> 
<legis-type>A BILL</legis-type> 
<official-title display="yes">To amend the Public Health Service Act to coordinate Federal congenital heart disease research efforts and to improve public education and awareness of congenital heart disease, and for other purposes.<pagebreak/></official-title> 
</form> 
<legis-body changed="added" committee-id="HIF00" display-enacting-clause="yes-display-enacting-clause" id="HF7FA0198ACDF4664B2FACBC5E8FA9013" reported-display-style="italic" style="OLC"> 
<section id="HACAB62209BDE4869A407193F135E32AD" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Congenital Heart Futures Reauthorization Act of 2017</short-title></quote>.</text> </section> <section id="H5927FDA73B724BC68CBEBCE1E2B7E854"><enum>2.</enum><header>National congenital heart disease surveillance system</header><text display-inline="no-display-inline">Section 399V–2 of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/280g-13">42 U.S.C. 280g–13</external-xref>) is amended to read as follows:</text> 
<quoted-block changed="added" committee-id="HIF00" display-inline="no-display-inline" id="HB16BA8F02DD94BCB988FDC17ED57D795" reported-display-style="italic" style="OLC"> 
<section id="HDC4BDE7CE88B4AA3A6A91EF25F6CC565"><enum>399V–2.</enum><header>National congenital heart disease research, surveillance, and awareness</header> 
<subsection id="H06F3EB73FC0145CB96E95944F96FF858"><enum>(a)</enum><header>In general</header><text>The Secretary shall—</text> <paragraph id="H8B94DDAE12CF478EB8E80A5976BE910D"><enum>(1)</enum><text>enhance and expand research and surveillance infrastructure to study and track the epidemiology of congenital heart disease (in this section referred to as <quote>CHD</quote>); and</text> </paragraph>
<paragraph id="H22C3A62A974B48B781685AA08B869C2C"><enum>(2)</enum><text>award grants to eligible entities to undertake the activities described in this section.</text> </paragraph></subsection> <subsection id="H84F770AAB47742868CEADE1F61030C4A"><enum>(b)</enum><header>National congenital heart disease study</header> <paragraph id="HA8AE5EBD60C641D8B47FAB7A5AAEDCAC"><enum>(1)</enum><header>In general</header><text>The Secretary shall plan, develop, implement, and submit one or more reports to the Congress on a study to improve understanding of the epidemiology of CHD across the lifespan, from birth to adulthood, with particular interest in the following:</text> 
<subparagraph id="HC3572F560B7E40D8B0DFB14CBFE57BC3"><enum>(A)</enum><text>Health care utilization of those affected by CHD.</text> </subparagraph> <subparagraph id="HF44920EAF3A84B038EF5F678228F1721"><enum>(B)</enum><text>Demographic factors associated with CHD, such as age, race, ethnicity, gender, and family history of individuals who are diagnosed with the disease.</text> </subparagraph>
<subparagraph id="HFDD18B31A7FA47C9953894BBFABE958C"><enum>(C)</enum><text>Outcome measures, such that analysis of the outcome measures will allow derivation of evidence-based best practices and guidelines for CHD patients.</text> </subparagraph></paragraph> <paragraph id="H38FB776D8B8C4BC9935E8FB6C9A92FC2"><enum>(2)</enum><header>Permissible considerations</header><text>The study under this subsection may—</text> 
<subparagraph id="H7A7C4E6C14184C8EA72D8F88363900EA"><enum>(A)</enum><text>gather data on the health outcomes of a diverse population of those affected by CHD;</text> </subparagraph> <subparagraph id="HCE65669E3A2843E28D18E3FD7D54924D"><enum>(B)</enum><text>consider health disparities among those affected by CHD, which may include the consideration of prenatal exposures; and</text> </subparagraph>
<subparagraph id="HBCADB34D545B42898B1F6DCAD35B9806"><enum>(C)</enum><text>incorporate behavioral, emotional, and educational outcomes of those affected by CHD.</text> </subparagraph></paragraph> <paragraph id="H65A14DB8E5494CF2850BA8CFC8CA7505"><enum>(3)</enum><header>Public access</header><text>Data generated from the study under this subsection shall be made available—</text> 
<subparagraph id="HA65EC1DB6DD94650867F93E9A77B150D"><enum>(A)</enum><text>for purposes of CHD research, subject to appropriate protections of personal privacy, including protections required by paragraph (4); and</text> </subparagraph> <subparagraph id="H0F3D7FDE12364C64BE4750A970BFCF24"><enum>(B)</enum><text>to the public, subject to paragraph (4) and with appropriate exceptions for protection of personal privacy.</text> </subparagraph></paragraph>
<paragraph id="HAF478B6B0C7B4631B8C5835B20DB5EB5"><enum>(4)</enum><header>Patient privacy</header><text>The Secretary shall ensure that the study under this subsection is carried out in a manner that complies with the requirements applicable to a covered entity under the regulations promulgated pursuant to section 264(c) of the Health Insurance Portability and Accountability Act of 1996.</text> </paragraph></subsection> <subsection id="HDF37951FAB85481BABE9F515CAC58366"><enum>(c)</enum><header>Eligibility for grants</header><text>To be eligible to receive a grant under subsection (a)(2), an entity shall—</text> 
<paragraph id="HF1B3528979394F32B1AB35B840A205CA"><enum>(1)</enum><text>be a public or private nonprofit entity with specialized experience in CHD; and</text> </paragraph> <paragraph id="H6A1AE3E0ED8E4C0A9EA4676BBE18EBA1"><enum>(2)</enum><text>submit to the Secretary an application at such time, in such manner, and containing such information as the Secretary may require.</text> </paragraph></subsection>
<subsection id="HAEF65A3B9AD6433AA24599D377E0FD89"><enum>(d)</enum><header>Authorization of appropriations</header><text>To carry out this section, there is authorized to be appropriated $4,000,000 for each of fiscal years 2018 through 2022.</text></subsection></section><after-quoted-block>.</after-quoted-block></quoted-block> </section> <section id="HC2A66AD664DF45E38E27B715B48FB6D0"><enum>3.</enum><header>Congenital heart disease research</header><text display-inline="no-display-inline">Section 425 of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/285b-8">42 U.S.C. 285b–8</external-xref>) is amended to read as follows:</text> 
<quoted-block changed="added" committee-id="HIF00" display-inline="no-display-inline" id="H9D64E79E353E43A6AACBF1BF53EAFBF9" reported-display-style="italic" style="OLC"> 
<section id="H51E7567779E445EB829E0802A2EBE466"><enum>425.</enum><header>Congenital heart disease</header> 
<subsection id="HC93CD749ECF64C7A8D9A909D4EE13A1B"><enum>(a)</enum><header>In general</header><text>The Director of the Institute may expand, intensify, and coordinate research and related activities of the Institute with respect to congenital heart disease, which may include congenital heart disease research with respect to—</text> <paragraph id="H8FD23CB3C23A48B6BF416859A2BA225B"><enum>(1)</enum><text>causation of congenital heart disease, including genetic causes;</text> </paragraph>
<paragraph id="HA78304CED6EF4C76B189E335A427683D"><enum>(2)</enum><text>long-term outcomes in individuals with congenital heart disease, including infants, children, teenagers, adults, and elderly individuals;</text> </paragraph> <paragraph id="H32C2B413CABB421987701F266D2B728B"><enum>(3)</enum><text>diagnosis, treatment, and prevention;</text> </paragraph>
<paragraph id="H7A404577205E445A8AA83BD5A757102D"><enum>(4)</enum><text>studies using longitudinal data and retrospective analysis to identify effective treatments and outcomes for individuals with congenital heart disease; and</text> </paragraph> <paragraph id="HCC6FAE59CF4A4F8EAEBB085D76AD8740"><enum>(5)</enum><text>identifying barriers to lifelong care for individuals with congenital heart disease.</text> </paragraph></subsection>
<subsection id="HD22959C885614758BF39310A6E0DC55A"><enum>(b)</enum><header>Coordination of research activities</header><text>The Director of the Institute may coordinate research efforts related to congenital heart disease among multiple research institutions and may develop research networks.</text> </subsection> <subsection id="H183DBAD19756455CBAFCBAB9A40ABD32"><enum>(c)</enum><header>Minority and medically underserved communities</header><text>In carrying out the activities described in this section, the Director of the Institute shall consider the application of such research and other activities to minority and medically underserved communities.</text> </subsection>
<subsection id="H0F3BB3B6C4164F578AC0CDDC65E7E67E"><enum>(d)</enum><header>Report from NIH</header><text>Not later than one year after the date of the enactment of the <short-title>Congenital Heart Futures Reauthorization Act of 2017</short-title>, the Director of NIH, acting through the Director of the Institute, shall provide a report to Congress—</text> <paragraph id="H4C2D87304A9F4D239A235121CD97E9A7"><enum>(1)</enum><text>outlining the ongoing research efforts of the National Institutes of Health regarding congenital heart disease; and</text> </paragraph>
<paragraph id="HECF467F6F5CD479D9D1BF5263F4AB6EB"><enum>(2)</enum><text>identifying—</text> <subparagraph id="H124093E802894C28B51A9704EBE3D380"><enum>(A)</enum><text>future plans for research regarding congenital heart disease; and</text> </subparagraph>
<subparagraph id="H00054CDE087E4885A56F5E655BB56C7A"><enum>(B)</enum><text>the areas of greatest need for such research.</text></subparagraph></paragraph></subsection></section><after-quoted-block>.</after-quoted-block></quoted-block> </section> </legis-body> <endorsement display="yes"> <action-date>September 25, 2017</action-date> <action-desc>Reported with an amendment, committed to the Committee of the Whole House on the State of the Union, and ordered to be printed</action-desc></endorsement> </bill> 

